Tarapore Kairus 4

4 · Xylem Inc. · Filed Mar 2, 2021

Form 4

Period: 2021-02-26

SVP & CHRO

Transactions

Sale
Common Stock
2021-02-26$99.95/sh−2,777$277,561→ 13,506 total
Award
Common Stock
2021-03-01+1,553→ 14,810 total
Tax Payment
Common Stock
2021-02-27$102.23/sh−249$25,455→ 13,257 total
Award
Stock Option (Right to Buy)
2021-03-01+6,843→ 6,843 total
Exercise: $102.23Exp: 2031-03-01→ Common (6,843 underlying)

Footnotes (5)

[F1]The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on November 6, 2020.
[F2]This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,777 shares that were executed at price of $99.95. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
[F3]Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 27, 2020 under the Xylem 2011 Omnibus Incentive Plan
[F4]Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024
[F5]Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024.

Documents

1 file